Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, making ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results